LITS (Lite Strategy) Days Payable: 0.00 (As of Mar. 2026)

What is Lite Strategy Days Payable?

Lite Strategy LITS +9.89% 22 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates LITS with a GF Score™ of 22/100. The stock has 2 warning signs investors should review. Among 706 Biotechnology companies, Lite Strategy ranks worse than 141642.92% on this metric.

Lite Strategy's average Accounts Payable for the three months ended in Mar. 2026 was $0.29 Mil. Lite Strategy's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.00 Mil.

The historical rank and industry rank for Lite Strategy's Days Payable or its related term are showing as below:

During the past 13 years, Lite Strategy's highest Days Payable was 1139.59. The lowest was 60.74. And the median was 360.89.

LITS's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.56
* Ranked among companies with meaningful Days Payable only.

Lite Strategy's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same

Lite Strategy Days Payable Related Terms

Lite Strategy Days Payable Historical Data

* Premium members only.

The historical data trend for Lite Strategy's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lite Strategy Days Payable Chart

Lite Strategy Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Days Payable

Get a 7-Day Free Trial

1,139.59

0.00

Lite Strategy Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

LITS vs SGMO, LSTA, NNVC: Days Payable Comparison

For the Biotechnology subindustry, Lite Strategy's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lite Strategy Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lite Strategy's Days Payable distribution charts can be found below:

* The bar in red indicates where Lite Strategy's Days Payable falls into.

Save Embed

22GF Score

Lite Strategy Inc LITS

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Lite Strategy Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Lite Strategy's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as

	Days Payable (A: Jun. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2024 )	+	Accounts Payable (A: Jun. 2025 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2025 )	*	Days in Period
=	( (3.168	+	0.176)	/	2 )	/	0	*	365
=	1.672					/	0	*	365
=	N/A

Lite Strategy's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

	Days Payable (Q: Mar. 2026 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2025 )	+	Accounts Payable (Q: Mar. 2026 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
=	( (0.327	+	0.253)	/	2 )	/	0	*	365 / 4
=	0.29					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

Lite Strategy (LITS) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Lite Strategy and its competitors. Over the past decade, Lite Strategy's Days Payable has ranged from 60.74 to 1,139.59. According to the industry distribution chart, Lite Strategy ranks #999999 out of 706 companies in the Biotechnology industry.

Is Lite Strategy's Days Payable too high?

Lite Strategy's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 60.74 to a high of 1,139.59. Based on the distribution chart, Lite Strategy ranks #999999 out of 706 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Lite Strategy has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.

How does Lite Strategy's Days Payable compare to SGMO and LSTA?

According to the Biotechnology industry distribution chart, Lite Strategy ranks #999999 out of 706 companies for Days Payable. This places Lite Strategy in the lower half of its industry. The industry median Days Payable is 113.56. Historically, Lite Strategy's own Days Payable has ranged from 60.74 to 1,139.59 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.56, based on 706 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Lite Strategy and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lite Strategy's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Lite Strategy stock overvalued right now?

Lite Strategy (LITS) has a current Days Payable of 0.00. The current Days Payable is 0.00. Lite Strategy's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For Lite Strategy (LITS), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lite Strategy Business Description

Industry Healthcare Biotechnology

Comparable Companies SGMO LSTA NNVC ATNM DARE DYAI GRDX TVGN KYNB PSTV VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges 0JW9:UK

Address 9920 Pacific Heights Boulevard, Suite 150, San Diego, CA, USA, 92121

Website https://www.litestrategy.com

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

22GF Score

Get the complete analysis for LITS

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.90

Price

View LITS Analysis

See Days Payable data for all stocks →